To the Editor, With great interest, we read the recent article by Gur et al. (1), “The effect of place of residence and lifestyle on vitamin D deficiency in pregnancy: Comparison of eastern and western parts of Turkey”. The authors discussed the prevalence and the predictive factors of vitamin D deficiency in pregnancy and the compliance with “The National Vitamin D Support Program” in Turkey’s easternmost and westernmost provinces. They found that clothing style, seaside holiday duration, consuming fish, living in high-altitude cold regions, and 1200 IU/day vitamin D supplementation affected vitamin D levels. They also showed that vitamin D deficiency in pregnancy is high in Turkey. They recommended increasing compliance with “The National Vitamin D Support Program” at the follow-up of all pregnant women. Vitamin D supplementation in early life is recommended to prevent vitamin D deficiency in many countries, raising important questions about the safety and benefit for immune development and the implications for allergic risk. The impact of vitamin D deficiency on the risk of developing an allergy and a child’s immune status in childhood has been controversial and lacking. We want to mention that vitamin D supplementation during pregnancy may promote the evolution of allergic diseases in offspring during childhood. In recent studies, vitamin D was found to be positively associated with the risk for the development of allergic diseases in children during their first 2 years of life. Weisse et al. demonstrated that in pregnancy and at birth, higher levels of vitamin D may contribute to a higher risk for allergic outcomes. A questionnaire was answered by parents during pregnancy and yearly thereafter about children’s atopic findings in the first 2 years of life. They also found a positive association between maternal and cord blood vitamin D concentrations with children’s risk for food allergy within the first years of life (2). In a prospective study, 596 pregnant women’s vitamin D concentrations were evaluated in pregnancy, and their children were followed about allergic diseases and growth parameters. An association was not found between maternal vitamin D level and the child’s anthropometric data or intelligence. Children whose mothers had a higher concentration of vitamin D had an increased risk of atopic dermatitis and asthma compared to children whose mothers had a lower concentration of vitamin D (3). Rothers et al. (4) found that those with cord blood vitamin D ≥100 nmol/L, when compared to children with cord vitamin D 50–74.9 nmol/L, had a greater risk of a positive response to a skin prick test. They also reported a non-linear relationship between cord vitamin D and IgE (allergen-specific and total).The highest levels of IgE were identified in children with a cord vitamin D concentration <50 nmol/L and ≥100 nmol/L. Increased risk of aeroallergen sensitization and elevated total IgE levels are associated with both low and high levels of vitamin D in cord blood. Nielsen et al. (5) reported that postpartum depression is associated with high levels of 25(OH)D3. They speculated that 24-hydroxylase is the main determinant of this situation. High levels of 25(OH)D3 stimulate the 24-hydroxylase enzyme, which degrades the active form of vitamin D, 1,25(OH)2D3, to the inactive 1,24,25-trihydroxyvitamin D3 metabolite. This results in low concentrations of intracellular 1,25(OH)2D3. So, they propose that either a low level of 25(OH)D3 or high level of 25(OH)D3 cause a low level of 1.25(OH)2D and subsequent insufficient stimulation of vitamin D receptors. Although the data to support this are still limited and heterogeneous, according to data, especially large doses of vitamin D supplementation during pregnancy should be used carefully. We hope that the items mentioned above will add to the value of the well-written article of Gur et al. (1) regarding vitamin D deficiency in pregnancy.